HNN3.0
Register
Register
Register

Project cooperationUpdated on 9 January 2026

Meaningful and Faithful Computational, Multi-omics Based Simulations of Cancer Evolution for Validation and Prediction

Professor at Università degli Studi di Milano-Bicocca

Milan, Italy

About

The number of analysis methods and tools developed to hash interpretations out of "data" (e.g., bulk and single-cell sequencing data, or imaging data for spatial transcriptomics) being published each year is enormous. Each of these tools needs "validation", which is usually done by running extensive simulations of the scenarios the researchers have in front.

However, there is not a clear notion yet of a "digital twin" against which to run these validation tests (*). This is particularly true in the field of (solid) tumor evolution.

We are therefore interested in pursuing the goal of producing a multi-omics and AI integrated tumor digital-twin capable of recapitulating spatial growth of a solid tumor in a tissue while tracking its genotype at the single-cell level. For this we are leveraging our previous work on colon cancer development and the distribution of a prototype single-cell lineage-aware simulator called J-Space.

(*) Towards credible digital twins for basic and preclinical research, Colleen E. Clancy & Bennett A. Landman, Nature Reviews, 2026-01-08.

Similar opportunities

  • Project cooperation

    Digital-twins for personalized medicine

    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches

    Giuseppe Sciume

    Associate Professor at University of Bordeaux

    Bordeaux, France

  • Project cooperation

    Myeloid cell therapy

    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Fernando Torres Andón

    Miguel Servet Researcher at INIBIC

    A Coruña, Spain

  • Project cooperation

    Cancer, Fibrosis and Coagulation

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Alessandra Metelli

    Researcher at IRCCS Regina Elena National Cancer Institute

    Rome, Italy